Intuitive Surgical Inc ISRG
Stock research in plain language · As of Oct 04, 2026 · updated once a week, after the trading week closes
What the company does
Intuitive Surgical Inc is a large-cap company in the Healthcare sector (Medical Instruments & Supplies), with a market value of $140.4B, based in the USA.
It employs about 17,021 people and has been listed since Jun 13, 2000.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
Cheap or expensive? relatively expensive
Its price-to-earnings (P/E) is 46.1 versus 31.6 for the median of the Healthcare sector in our universe (22 companies) — relatively expensive.
Revenue is growing 18% a year — the market is paying ahead for that growth. If it slows, the high multiple becomes the risk.
On analysts' next-year forecasts the multiple drops to 33.3 — they expect higher earnings.
The average analyst price target is 476.34, 22% above the current price (their view, not ours).
The stock sits at 23% of its one-year range (0% = the low, 100% = the high).
The risks
- • The stock is 35% below its one-year high.
Strengths
- ✅ Profitable — 28 of every 100 dollars of revenue stays as profit.
- ✅ Generates free cash flow — profit becomes cash in the bank.
- ✅ Buys back its shares (2% fewer shares in a year).
- ✅ Most analysts rate it buy (24 vs 1).
- ✅ Revenue is growing 18% a year.
What changed this week
Over the past week the stock fell 3.3% (for comparison: S&P 500 -0.2%, sector ETF XLV -2.6%).
This week's news
- Ferrari (RACE): Is Its Scarcity-Driven Luxury Moat Unbreakable? finance.yahoo.com · 2026-10-04
- Philip Morris (PM): Is Its Smoke-Free Transformation a Durable Growth Engine? finance.yahoo.com · 2026-10-04
- Moody’s (MCO): Is Its Credit-Ratings Duopoly Moat Unbreakable? finance.yahoo.com · 2026-10-04
- Intuitive Surgical (ISRG): Is Its Robotic-Surgery Moat Still Untouchable? finance.yahoo.com · 2026-10-03
- Can ISRG Offset China Weakness With Expansion in India and Japan? finance.yahoo.com · 2026-10-02
- 10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises finance.yahoo.com · 2026-09-30
A description of facts from the filings and the market — not investment advice or a recommendation. "Cheap" and "expensive" are always relative to the comparison group.